The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.
As of close of business last night, Lucid Diagnostics Inc’s stock clocked out at $1.23, down -1.60% from its previous closing price of $1.25. In other words, the price has decreased by -$1.60 from its previous closing price. On the day, 0.76 million shares were traded.
Ratios:
To gain a deeper understanding of LUCD’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.03 and its Current Ratio is at 1.07. In the meantime, Its Debt-to-Equity ratio is 3.94 whereas as Long-Term Debt/Eq ratio is at 0.33.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Ascendiant Capital Markets on December 27, 2021, initiated with a Buy rating and assigned the stock a target price of $16.
On November 08, 2021, Needham started tracking the stock assigning a Buy rating and target price of $17.
On November 08, 2021, Cantor Fitzgerald started tracking the stock assigning a Overweight rating and target price of $21.Cantor Fitzgerald initiated its Overweight rating on November 08, 2021, with a $21 target price.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 29.80.
Stock Price History:
Over the past 52 weeks, LUCD has reached a high of $1.80, while it has fallen to a 52-week low of $0.68. The 50-Day Moving Average of the stock is -10.47%, while the 200-Day Moving Average is calculated to be 21.17%.
Shares Statistics:
A total of 63.07M shares are outstanding, with a floating share count of 40.01M. Insiders hold about 62.03% of the company’s shares, while institutions hold 4.27% stake in the company.
